Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
113.00    1.50 (1.35%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £67.98m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Board Changes

30 Jun 2022 07:00

RNS Number : 7245Q
Intercede Group PLC
30 June 2022
 

30 June 2022

Intercede Group plc

 

("Intercede", the "Group" or the "Company")

 

Board Changes

 

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce that Royston Hoggarth, Non-Executive Director of the Company will succeed Chuck Pol as the Company's Chairman. Chuck Pol has been Chairman for the last four years, during which time the Group has considerably strengthened its market position and is now well positioned for the future. Chuck will step back into a Non-Executive role with immediate effect.

 

The Company is also delighted to announce the appointment of Tina Whitley as Independent Non-Executive Director with effect from 1 July 2022. Tina has over 30 years' experience across the information technology sector. She currently holds the position of CEO at NEC Software Solutions, a provider of specialist software and services for the public sector. Previously she was the Managing Director responsible for the Capita SIMS Further Education and Libraries businesses and, prior to Capita Group, she was Director of Operations at Convergys. She has extensive commercial, operational and technical experience.

 

Intercede CEO Klaas van der Leest said:

 

"I am delighted that Royston has elected to step up to the role of Chairman. Having worked with Royston for many years, I am looking forward to working more closely through the next phase of Intercede's strategic development. On behalf of the Board, I want to thank Chuck for his support and leadership as Chairman during what was a very challenging time for the Group."

 

"We are delighted to announce Tina's appointment as Non-Executive Director. She brings extensive relevant experience which will be of great value as we look to execute our growth plans."

 

 

 

ENQUIRIES

 

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

finnCap Ltd.

Tel. + 44 (0)20 7220 0500

Simon Hicks/Fergus Sullivan

Corporate Finance

Tim Redfern/Charlotte Sutcliffe

ECM

 

 

 

Regulatory disclosures

 

The following information regarding Tina Jane Whitley, aged 53, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Current Directorships

Directorships held in past 5 years

APD Communications Limited

(None)

APD Mobile Data Limited

 

Argon NPS (Holdings) Limited

 

Argon NPS Limited

 

Argon Topco Limited

 

Charter Systems Limited

 

Digital Healthcare Limited

 

Garden Private Holdings Limited

 

Health Information Systems (UK) Limited

 

i2N Ltd

 

Medical Imaging UK Limited

 

MIDRSS Limited

 

NEC Software Solutions ANZ Pty Limited

 

NEC Software Solutions Canada Limited

 

NEC Software Solutions India Pvt Limited

 

NEC Software Solutions UK Limited

 

Northgate Public Services Limited

 

NPS (Holdings) Limited

 

NPS (UK11) Limited

 

NPS (UK13) Limited

 

Rave Technologies (UK) Limited

 

Rave Technologies USA Inc

 

SX3 Limited

 

Vantage Diagnostics Ltd

 

Vantage Health Limited

 

We Are Snook Limited

 

 

 

 

There are no other matters which are required to be announced under Schedule 2(g) of the AIM Rules for Companies.

 

 

About Intercede

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

For more information visit: www.intercede.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKCBQCBKDOAB
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
26th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.